4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001714899-24-000092
Director sold 1,666 shares at $20.10 ($33,487)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
SATO VICKI L · Director
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-03-15 | Sale : show line 1 in the form 10b5-1 | −1,666 | $20.10 | $33,487 | 119,709 | D |
| Open-market sales · 1,666 sh · avg $20.10 · $33,487 | ||||||
Loading xslF345X05/wk-form4_1710880039.xml…